Quinapril/Hydrochlorothiazide Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Quinapril/Hydrochlorothiazide Tablet (tablet) from Chartwell Molecular Holdings LLC with status Current. The shortage was first posted on 01/19/2023.
Shortage Details
- Status
- Current
- Company
- Chartwell Molecular Holdings LLC
- Package NDC
- 62135-667-90
- Dosage Form
- Tablet
- Presentation
- Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 62135-667-90)
- Initial Posting
- 01/19/2023
- Revised Date